Announced Mon, 25 May · 18:13 IST

Resignation of Interim CFO: Pursuant to the approval accorded by the Board of Directors at its meeting held on May 19, 2026, for the appointment of Mr. Sanjeev Kumar as the Chief Financial Officer and Key Managerial Personnel of the Company, and consequent upon his assumption of office with effect from May 25, 2026, Dr. Manish Mattoo, Executive Director and Chief Executive Officer of the Company, has relinquished the additional charge of Interim Chief Financial Officer of the Company with effect from May 25, 2026.

Kmp ResignedManagement Changes View source PDF

HCG · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.3%1-day move
₹658.00
prior close
₹648.35
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.8+0.4+0.6+0.4+0.3-3.5-1.8-3.9-3.8-3.0-4.1-9.7+3.5
Up moveDown movePending
AI summary

Healthcare Global Enterprises Limited (HCG) announced that Dr. Manish Mattoo, who also serves as Executive Director and CEO, has stepped down from the additional charge of Interim Chief Financial Officer effective May 25, 2026. This resignation follows the appointment of Mr. Sanjeev Kumar as the permanent Chief Financial Officer and Key Managerial Personnel (KMP) of the company, whose appointment was approved by the Board of Directors on May 19, 2026, and assumed office on May 25, 2026. Dr. Mattoo had been holding the Interim CFO role since December 1, 2025, until a new CFO was appointed. He will continue in his role as Executive Director and CEO of the company.

Likely market impact

This is a routine executive transition following the appointment of a permanent CFO. Dr. Mattoo remains as CEO, so there is no leadership void. The company has successfully transitioned from interim to permanent CFO arrangements, which should bring stability to the finance function.